Decision Biomarkers, Inc. (DBI) is a life sciences company that has pioneered the development of an automated multiplex immunoassay platform (The Avantra™ Q400 Biomarker Workstation) and biomarker panel assays, both custom (iMARK BIOCHIP™) and standard biochips (MAX BIOCHIP™). Our proprietary system enables pharmaceutical, academic and biotech researchers to conduct high-accuracy biomarker analysis quickly and cost-effectively through all stages of drug development.
Last Updated: 12-22-2006